Orthofix Medical (OFIX) Net Income towards Common Stockholders (2010 - 2026)

Orthofix Medical has disclosed Net Income towards Common Stockholders across 17 years of filings, most recently posting -$20.9 million for Q1 2026.

• Quarterly Net Income towards Common Stockholders rose 60.62% year-over-year to -$20.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $33.3 million (up 123.25% YoY) and the FY2025 annual result came in at $1.1 million, up 100.86% from the prior year.
• Net Income towards Common Stockholders retreated to -$20.9 million in Q1 2026, from $91.1 million in the prior quarter.
• Over five years, Net Income towards Common Stockholders peaked at $132.6 million in Q4 2023 and troughed at -$60.9 million in Q1 2023.
• A 5-year average of -$9.5 million and a median of -$22.8 million in 2025 frame the typical range for Net Income towards Common Stockholders.
• Biggest YoY gain for Net Income towards Common Stockholders was 1977.94% in 2023; the steepest drop was 1684.01% in 2023.
• Tracing OFIX's Net Income towards Common Stockholders over 5 years: stood at -$7.1 million in 2022, then soared by 1977.94% to $132.6 million in 2023, then slumped by 121.98% to -$29.1 million in 2024, then soared by 412.4% to $91.1 million in 2025, then plunged by 122.96% to -$20.9 million in 2026.
• Business Quant data shows OFIX's Net Income towards Common Stockholders at -$20.9 million in Q1 2026, $91.1 million in Q4 2025, and -$22.8 million in Q3 2025.